A detailed history of Stephens Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Stephens Inc holds 6,841 shares of HALO stock, worth $414,769. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,841
Previous 9,183 25.5%
Holding current value
$414,769
Previous $480,000 18.54%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$51.3 - $64.42 $120,144 - $150,871
-2,342 Reduced 25.5%
6,841 $391,000
Q2 2024

Aug 06, 2024

SELL
$37.81 - $52.4 $1,361 - $1,886
-36 Reduced 0.39%
9,183 $480,000
Q1 2024

May 15, 2024

BUY
$33.68 - $41.95 $98,682 - $122,913
2,930 Added 46.59%
9,219 $375,000
Q4 2023

Feb 13, 2024

BUY
$33.32 - $42.1 $5,297 - $6,693
159 Added 2.59%
6,289 $232,000
Q3 2023

Nov 14, 2023

BUY
$36.46 - $44.03 $9,297 - $11,227
255 Added 4.34%
6,130 $234,000
Q2 2023

Aug 14, 2023

BUY
$30.28 - $38.74 $89,416 - $114,399
2,953 Added 101.06%
5,875 $211,000
Q1 2023

May 15, 2023

BUY
$32.86 - $55.7 $755 - $1,281
23 Added 0.79%
2,922 $111,000
Q1 2022

May 04, 2022

BUY
$31.97 - $41.06 $11,796 - $15,151
369 Added 14.58%
2,899 $116,000
Q1 2021

May 14, 2021

BUY
$39.51 - $51.45 $79,020 - $102,900
2,000 Added 377.36%
2,530 $105,000
Q4 2020

Feb 10, 2021

SELL
$25.81 - $43.62 $67,183 - $113,542
-2,603 Reduced 83.08%
530 $23,000
Q3 2020

Nov 13, 2020

SELL
$25.74 - $29.63 $22,316 - $25,689
-867 Reduced 21.68%
3,133 $82,000
Q2 2020

Aug 24, 2020

BUY
$16.25 - $26.81 $65,000 - $107,240
4,000 New
4,000 $107,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.45B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Stephens Inc Portfolio

Follow Stephens Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.